Case Report: mRNA vaccination-mediated STAT3 overactivation with agranulocytosis and clonal T-LGL expansion

Vaccines against SARS-CoV-2 are the most effective measure against the COVID-19 pandemic. The safety profile of mRNA vaccines in patients with rare diseases has not been assessed systematically in the clinical trials, as these patients were typically excluded. This report describes the occurrence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirsiger, Julia R., Tzankov, Alexandar, Alborelli, Ilaria, Recher, Mike, Daikeler, Thomas, Parmentier, Stefani, Berger, Christoph T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933345/
https://www.ncbi.nlm.nih.gov/pubmed/36817454
http://dx.doi.org/10.3389/fimmu.2023.1087502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933345/
https://www.ncbi.nlm.nih.gov/pubmed/36817454
http://dx.doi.org/10.3389/fimmu.2023.1087502

Ejemplares similares